Cytrx Stock Price - CYTR

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$40.31
SMALL CAP PRO
Monthly Subscription
for only
$43.59
ULTIMATE TRADER
Monthly Subscription
for only
$65.99
VAT not included
After Hours
Last Trade
Last: $ 0.52 ▲ 0.01 (1.22%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Cytrx Corp. (MM) CYTR NASDAQ Common Stock US2328285091
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.1759 -25.69% 0.5088 0.5575 0.497 0.547 0.6847 20:00:00
Bid Price Ask Price Spread Spread % News
0.51 0.53 0.02 3.77% 1 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
52,009 25,738,684 $ 0.5293 $ 13.62M 3.48M 0.36 - 3.44
Last Trade Time Type Quantity Stock Price Currency
19:59:31 formt 1,000 $0.52 USD

Cytrx Corp. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 59.69M 117.32M $ -50.77M -0.63 0.00 114.14M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.2M $ 0.00 0.00% - 19.40%

more financials information »

Cytrx Corp. (MM) News

Date Time Source News Article
4/28/201715:14Edgar (US Regulatory)Current Report Filing (8-k)
4/28/201707:51PR Newswire (US)CytRx Corporation Announces Pricing of $15 Million Public..
4/27/201717:55PR Newswire (US)CytRx Corporation Announces Proposed Public Offering of..
4/27/201717:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)
4/24/201706:01Edgar (US Regulatory)Notice of Effectiveness (effect)
4/21/201709:00PR Newswire (US)CytRx to Present Aldoxorubicin Clinical Trial Data in..
4/19/201713:15Edgar (US Regulatory)Current Report Filing (8-k)

Historical CYTR Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.5250.9890.4970.00009M51M22M-0.0162-3.09%
1 Month0.440.9890.420.0000551k51M8M0.068815.64%
3 Months0.4250.9890.38130.0000349k51M3M0.083819.72%
6 Months0.480.9890.3610.0000215k51M2M0.02886.00%
1 Year3.253.440.3610.0000215k51M2M-2.7412-84.34%
3 Years3.585.460.3610.0000051M1M-3.0712-85.79%
5 Years2.71328.350.3610.0000051M1M-2.2044-81.25%

Cytrx Corp. (MM) Description

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170429 23:30:21